Delivery Order SPE2DB22D2206-SPE2DB24FKD00

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick medication. The contract is a firm fixed-price arrangement with a ceiling value of $1,051.98 and a period of performance through March 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Repatha (140 mg/mL SureClick) at a ceiling value of $2,033.64. The contract has a firm fixed price and an ultimate completion date of October 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick medication. The contract has a ceiling value of $5,096.40 and is a firm fixed-price delivery order with a performance period ending on May 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Repatha 140 mg/mL SureClick medication. The contract is a Delivery Order valued at $1,735.70 with a firm fixed price. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick medication. The contract has a total ceiling value of $1,041.42 and a performance period extending through May 20, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a Delivery Order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha 140 mg/mL SureClick medication, with a ceiling value of $3,124.26 and a performance period ending on June 30, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick medication. The contract has a ceiling value of $1,753.30 and a period of performance through March 6, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha, a 140 mg/mL SureClick medication, with a firm fixed price ceiling value of $39,131.13 and a period of performance through April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha, a 140 mg/mL SureClick medication, with a ceiling value of $1,041.42 and a completion date of April 14, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick medication. The contract has a ceiling value of $2,629.95 and runs through April 2, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKD00
    Delivery Order

This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Repatha 140 mg/mL SureClick medication. The contract has a ceiling value of $3,892.23 and an ultimate completion date of September 5, 2024. The contract type is Firm Fixed Price. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/4/24, 9:10 AM